| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairperson &CEO
1 company
Rothblatt Martine A is a Chairperson &CEO at UTHR. Recent filings cover 0 purchases and 462 sales. Those positions are worth an estimated $175.2M at current prices.
Our model assigns Rothblatt Martine A a middling insider score of 58/100, based on 304 past trades. Over a 12-month horizon, 53.6% of those trades were profitable, with an average 12-month return of -1.6%.
Rothblatt Martine A's largest disclosed position is in UTHR as Chairperson &CEO, worth about $175.2M. The recent filings there lean toward selling, a net 355,916 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $494.55 | $4,698,270.73 | -2.8% | |
| Sep 18, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $494.79 | $4,700,504.68 | -2.8% | |
| Sep 17, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $496.06 | $4,712,580.47 | -2.8% | |
| Sep 16, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,554 | $500.65 | $4,783,181.32 | -2.9% | |
| Sep 15, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $501.59 | $4,765,119.29 | -2.8% | |
| Sep 14, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $504.12 | $4,789,151.96 | -2.8% | |
| Sep 11, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $500.82 | $4,757,773.38 | -2.8% | |
| Sep 10, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $502.35 | $4,772,295.20 | -2.8% | |
| Sep 9, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $501.84 | $4,767,467.20 | -2.8% | |
| Sep 8, 2026 | UTHR United Therapeutics Corporation | Chairperson &CEO | Sale+OE | 9,500 | $499.03 | $4,740,795.40 | -2.8% |